Tag: PBMD

Blue Horseshoe Stocks: OHGI, OPXA Recaps & More

One Horizon Group, Inc. OHGI

We tagged OHGI in yesterday morning’s Extended Watchlist after catching it on a routine news scan, and were monumentally pleased to have done so. The interesting PR (Check out the link below) began a feeding frenzy which would boost the price of the stock exponentially.

The trading range on the day ran from an early low of 2.35, up to a new 52-week high of 5.84 on 45X the 3-month average volume, providing traders with the chance at gains of up to 148%, and we certainly hope some of our readers were among those to take advantage of the move!

The stock drew back to close at 4.30, and is gapping-down further in the premarket this morning so we’ll want to keep our eyes peeled for a bottom, and potential bounce-play opportunity.

Opexa Therapeutics, Inc. OPXA

OPXA put up a nice performance yesterday for the second straight day. We first tagged the stock on Wednesday, at which time we observed a low of .43 and a nice 26% move to .54 that day.

Yesterday, it continued to push the envelope, running from the daily low of .57 to .73; that was another good intraday run of 28%, and a total increase of 70% over our observed low from the prior session. OPXA is gapping up slightly in premarket trading, and we will leave it on our radars as we head into the weekend.

Pazoo, Inc. PZOO

We also want to touch briefly on PZOO, which sent out a new PR this morning alluding to further expansion into the cannabis sector. It also contains a reminder and details on the grand opening of the marijuana testing facility of Pazoo’s partner, MA & Associates coming up next week in Las Vegas.

As far as the chart is concerned, PZOO has been doing a good job of maintaining support above the 50DMA and building higher lows, which is what we’ve been looking for it to do. Now we’d like to see it break through the channel between its most recent swing high of .015 and the 200DMA of .018.

WHIPPANY, N.J., May 29, 2015 (GLOBE NEWSWIRE) — Pazoo, Inc. (OTC:PZOO) is pleased to report that it has formed a 100% wholly owned subsidiary called CannabisKing Distribution LLC. CannabisKing has been formed to be the marketing and sales agent for the distribution of non-controlled hemp products throughout the USA..>> READ FULL PR

Side Note – Trader’s Chat

We also ran across a big winner in AURI in our trader’s chatroom yesterday. The performance after we mentioned it to our members was staggering. It started out as low as .0019 subsequent to our 9:33am alert, and ran to .0045 (+137%). That was followed by a dip back to .0027 before it went on an absolute tear for the remainder of the session, hitting a high of .0075 (+177%).

This is why we always encourage our blog and/or newsletter readers to get involved in our chats if they have interest in doing so. Many winning opportunities not included in our premarket reports are offered up by ourselves and our members all the time! If you want to participate, all you need to do is send a Skype Contact Request to ‘stocksumo’.

Extended Watchlist:
PBMD, TBIO, PPHM, DCTH, DARA

Blue Horseshoe Stocks: AAPL Recap, MDCN News & More

Apple, Inc. AAPL – Options Recap

To start things off this week we want to look back to Friday’s report wherein we suggested that $131 and $132 Weekly Calls would be in play for possible daytrading opportunities, and our assertion was spot-on. The trading range on the $131 Calls was from .63-1.98, which was an overall spike of 214%, while the $132’s jumped from .14 to 1.00; a total increase of 614%

Those ranges, while extremely impressive, only reflect a fraction of the total possible gains for folks with daytrading ability. As you can see on the following chart snapshots of Friday’s intraday activity, these AAPL Calls were both what we commonly refer to as a “Flipper’s Dream”. Not one, but three big swings could have provided major ammunition for top-shelf profits.

Medican Enterprises, Inc. MDCN

MDCN is a marijuana-related stock that we’ve tracked in the past that has cropped up with a noteworthy PR this morning that we think our readers ought to check out.

Additionally, following a huge a huge run in late March, the stock has been under serious consolidation so it also qualifies as a potential bottom play as well. This will definitely be one to keep on our radars this week.

More News Plays
Here are a couple morning gappers with hefty PRs hitting the wires today:

IntelliPharmaCeutics International, Inc. IPCI

Live Person, Inc. LPSN

Extended Watchlist:
PBMD, ISR, CERU, JDST, AEZS

Blue Horseshoe Stocks: Recap of Yesterday’s Huge Session

Our first order of business today will be to go over the wealth of premium gain opportunities contained in yesterday’s premarket report. We had not one, but three of our selections make major moves, not to mention a couple of other modest gainers.

Prima BioMed, Ltd. PBMD

Quickly shooting to the top of our watchlist was PBMD. Its performance was exhilarating to behold as the stock went on an absolute tear from a low of 2.08 on up to 6.48. It marked an epic intraday run which produced total possible gains on the order of 211%

The move occurred on monstrous volume to the tune of nearly 62X the 3-month average, and stemmed largely from some positive results on one of the company’s trial drugs, announced Tuesday. >> READ PR

With the kind of momentum we’ve witnessed building up in just a single session from PBMD, we’re very interested to continue to follow the price action. A significant dip-and-rip scenario could soon present itself.

IsoRay, Inc. ISR

We also tagged ISR in yesterday’s extended watchlist, and it too shot up rapidly with the help of optimistic results from one of its own drug trials. From an early low of 1.86, the stock ran up as high as 3.38, carving out an intraday rip of 82%

This morning, we saw ISR go as high as 4.00 in premarket trading, extending the overnight range on this play to an eyebrow-raising 115%

We’ll certainly be monitoring this stock as we cruise into week’s end. Like PBMD, we’ll be on the lookout for profit-taking to possibly put a dip-and-rip scenario into effect.

Holiday Island Holdings, Inc. HIHI

In our closing thought from yesterday’s report, we called attention to a massive one-third share reduction being enacted by HIHI, and were extremely pleased to have done so. From a low of .0015, the stock broke out to hit .00265; a healthy move totaling 76%

We then saw it pull back into the close, but we’re not finished monitoring the stock by any means. We caught wind of a promotion (in which we are not involved) going out on HIHI this morning, which could provide us with an impeccably-timed boost to extend our profits as we look to take them off the table.

In light of the monumental performances we’ve seen out of news-fueled pharma plays this week, we’ve dug up a few more this morning for us to pin to our watchlists:

Calithera Biosciences, Inc. CALA

Actinium Pharmaceuticals, Inc. ATNM

Ampio Pharmaceuticals, Inc. AMPE

Extended Watchlist:
NSPR, CTP, AVEO